| Item | Cat. No. | Type | Clone No |
| Anti-C5AR1/CD88 mAbs [Izastobart Biosimilar] (MABL-4832) | MABL-4832 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-ADAM9 mAbs [Izeltabart Biosimilar] (MABL-4833) | MABL-4833 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB (Canine) mAbs [Izenivetmab Biosimilar] (MABL-4834) | MABL-4834 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-ICOS/CD278;PDCD1/CD279/PD1 mAbs [Izuralimab Biosimilar] (MABL-4835) | MABL-4835 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-CEACAM5/CD66e mAbs [Labetuzumab Biosimilar] (MABL-4836) | MABL-4836 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CSF1 mAbs [Lacnotuzumab Biosimilar] (MABL-4837) | MABL-4837 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-KIR3DL2/CD158K mAbs [Lacutamab Biosimilar] (MABL-4838) | MABL-4838 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SLC39A6/ZIP6 mAbs [Ladiratuzumab Biosimilar] (MABL-4839) | MABL-4839 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CFD mAbs [Lampalizumab Biosimilar] (MABL-4840) | MABL-4840 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-KLKB1 mAbs [Lanadelumab Biosimilar] (MABL-4841) | MABL-4841 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Lancastotug Biosimilar] (MABL-4842) | MABL-4842 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MSTN/GDF8/GDF-8 mAbs [Landogrozumab Biosimilar] (MABL-4843) | MABL-4843 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CCR8/CKR-L1/CDw198 mAbs [Lanerkitug Biosimilar] (MABL-4844) | MABL-4844 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-EGFR/ERBB1/HER1 mAbs [Laprituximab Biosimilar] (MABL-4845) | MABL-4845 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADPRC1/CD38 mAbs [Isatuximab Biosimilar] (MABL-4817) | MABL-4817 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Iscalimab Biosimilar] (MABL-4818) | MABL-4818 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADAMTSL5;ALB mAbs [Isecarosmab Biosimilar] (MABL-4819) | MABL-4819 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A mAbs [Ispectamab Biosimilar] (MABL-4820) | MABL-4820 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IGF1R/CD221;ERBB3/HER3 mAbs [Istiratumab Biosimilar] (MABL-4821) | MABL-4821 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-MICA&MICB mAbs [Isuventatug Biosimilar] (MABL-4822) | MABL-4822 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
